Pancreatic Stone Protein (PSP) earns its place in the 2026 Surviving Sepsis Campaign International Guidelines.
The new guidelines emphasise the increasing role of rapid diagnostic tools enabling early sepsis detection across emergency and critical care settings.
Pancreatic Stone Protein, running exclusively on the abioSCOPE® platform, is identified as a biomarker for early sepsis detection, validating its unique performance even in clinically confounding cases.
The updated guidelines are available here:https://link.springer.com/article/10.1007/s00134-026-08361-1
A summary of the guidelines is available here:
Latest Articles
Sepsis, ESICM, abionic, PSP, Surviving Sepsis Campaign, Pancreatic Stone Protein
Pancreatic Stone Protein (PSP) earns its place in the 2026 Surviving Sepsis Campaign International Guidelines. The new guidelines emphasise the inc...
